BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 34147723)

  • 1. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
    Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S
    Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy.
    Xu W; Pang C; Song C; Qian J; Feola S; Cerullo V; Fan L; Yu H; Lehto VP
    Acta Biomater; 2022 Oct; 152():473-483. PubMed ID: 36087872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
    Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
    Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy.
    Li L; Yang S; Song L; Zeng Y; He T; Wang N; Yu C; Yin T; Liu L; Wei X; Wu Q; Wei Y; Yang L; Gong C
    Theranostics; 2018; 8(3):860-873. PubMed ID: 29344312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
    Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
    Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Immunosuppressive Microenvironment in Acquiring Immunotolerance Post-Photothermal Therapy.
    Cherukula K; Park MS; Sontyana AG; Mathew AP; Vijayan V; Bae WK; Park IK
    J Korean Med Sci; 2019 Nov; 34(44):e272. PubMed ID: 31726492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin-Functionalized Gold Nanorods Loaded with Meclofenamic Acid for Improving
    Liu J; Song Y; Wang Y; Han M; Wang C; Yan F
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40612-40623. PubMed ID: 36053499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
    Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
    Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect.
    Chen B; Huang R; Zeng W; Wang W; Min Y
    Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors.
    Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J
    Front Immunol; 2023; 14():1279221. PubMed ID: 37942337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage.
    Huang TY; Huang GL; Zhang CY; Zhuang BW; Liu BX; Su LY; Ye JY; Xu M; Kuang M; Xie XY
    Front Chem; 2020; 8():1. PubMed ID: 32117862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy.
    Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H
    Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
    Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO
    Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
    Sun W; Du Y; Liang X; Yu C; Fang J; Lu W; Guo X; Tian J; Jin Y; Zheng J
    Biomaterials; 2019 Oct; 217():119264. PubMed ID: 31260883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
    Yasothamani V; Vivek R
    J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.